Radiopharm Theranostics Limited American Depositary Shares (RADX) — Working Capital to Net Assets Ratio
Radiopharm Theranostics Limited American Depositary Shares (RADX) has a Working Capital to Net Assets ratio of 61.6% as of December 2025. Working capital of $30.72 Million (current assets of $46.00 Million minus current liabilities of $15.28 Million) is measured against net assets of $49.89 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Radiopharm Theranostics Limited American financial flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Radiopharm Theranostics Limited American Depositary Shares Working Capital to Net Assets (2022–2025)
This chart shows how Radiopharm Theranostics Limited American Depositary Shares's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2022 to 2025. As of December 2025, the ratio stands at 61.6%, reflecting working capital of $30.72 Million against net assets of $49.89 Million USD. See Radiopharm Theranostics Limited American defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Radiopharm Theranostics Limited American Depositary Shares (2022–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Radiopharm Theranostics Limited American Depositary Shares from 2022 to 2025, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Radiopharm Theranostics Limited American stock valuation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 58.1% | $24.92 Million | $42.87 Million | $39.85 Million | $14.93 Million | ▲ +38.9 pp |
| 2024 | 19.3% | $5.27 Million | $27.35 Million | $22.85 Million | $17.58 Million | ▲ +12.5 pp |
| 2023 | 6.7% | $3.07 Million | $45.58 Million | $16.30 Million | $13.23 Million | ▼ -24.1 pp |
| 2022 | 30.8% | $19.39 Million | $62.96 Million | $27.26 Million | $7.88 Million | — |